Funding for this research was provided by:
Received: 5 March 2020
Accepted: 6 May 2020
First Online: 11 May 2020
Ethics approval and consent to participate
: Written informed consent was obtained from each patient included in the study. The study protocol conforms to the ethical guidelines of the Declaration of Helsinki. The study protocol was approved by the ethic committee of the Amsterdam UMC.
: Not applicable’.
: E.S.G.S. reports that his institution has received lecturing fees and advisory board fees from Amgen Inc., Regeneron, Sanofi, Akcea, Novartis and Athera. All other authors declared no conflict of interest.